Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells

被引:0
|
作者
Nagaya, N. [1 ]
Nagata, M. [1 ]
Ashizawa, T. [1 ]
Lu, Y. [1 ]
Fujita, K. [1 ]
Horie, S. [1 ]
机构
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2023.10.401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
275P
引用
收藏
页码:S1579 / S1580
页数:2
相关论文
共 50 条
  • [1] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [2] Circulating tumor cells in metastatic castration-resistant prostate cancer
    Brian I. Rini
    Current Oncology Reports, 2009, 11 : 163 - 164
  • [3] Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer
    Wang, Jasmine J.
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Cook-Wiens, Galen
    Yao, Nu
    Chu, Gina C.
    Chen, Pin-Jung
    Yang, Yingying
    Yeo, Yee Hui
    Lee, Yi-Te
    Chung, Leland W.
    You, Sungyong
    Zhu, Yazhen
    Freeman, Michael R.
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin M.
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy
    Derlin, Thorsten
    Riethdorf, Sabine
    Schumacher, Udo
    Lafos, Marcel
    Peine, Sven
    Coith, Cornelia
    Ross, Tobias L.
    Pantel, Klaus
    Bengel, Frank M.
    PROSTATE, 2023, 83 (11): : 1076 - 1088
  • [6] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhenchao Zhang
    Rui Luo
    William K. Kelly
    Joshua Chen
    Shane Donahue
    Kevan Ip
    Nathan R. Handley
    William J. Tester
    Miranda L. Tsang
    Felix J. Kim
    Ronald Myers
    Grace Lu-Yao
    Jian Gu
    Jianqing Lin
    Bingshan Li
    Chun Wang
    Hushan Yang
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 339 - 347
  • [7] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhang, Zhenchao
    Luo, Rui
    Kelly, William K.
    Chen, Joshua
    Donahue, Shane
    Ip, Kevan
    Handley, Nathan R.
    Tester, William J.
    Tsang, Miranda L.
    Kim, Felix J.
    Myers, Ronald
    Lu-Yao, Grace
    Gu, Jian
    Lin, Jianqing
    Li, Bingshan
    Wang, Chun
    Yang, Hushan
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 339 - 347
  • [8] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Pleskow, H.
    Otani, K.
    Kusaka, E.
    Ukleja, J.
    Balza, R.
    Fisher, R.
    Broderick, K.
    Maheswaran, S.
    Haber, D.
    Saylor, P. J.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
  • [9] Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.
    Lee, Florence
    Yu, Angela
    Anderson, Amanda
    Marrinucci, Dena
    Magargal, Wells W.
    DiPippo, Vincent A.
    Olson, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [10] Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Autio, Karen A.
    Anand, Aseem
    Krupa, Rachel
    Louw, Jessica
    Arslan, Zaina
    Dittamore, Ryan
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)